Clinical and Financial Impact of an Evidenced-Based Adhesive Small Bowel Obstruction Management Protocol

Withdrawn before enrolling · Not applicable

Conditions studied: Intestinal Obstruction

In brief

This research study is for patients with adhesive small bowel obstruction (ASBO). ASBO is a condition in which the small intestine gets blocked due to scars called adhesions. To see the blockage, a contrast agent is given and an x-ray is taken of the belly (abdomen). MD Gastroview and omnipaque are two contrast agents that may be given as part of your normal care for ASBO. This study hopes to see if one is better than the other.

Key facts

Study ID

NCT02928458

Run by

The Guthrie Clinic

People needed

0

Starts

2015-09-01

Expected to finish

2017-09-13

Last updated by the study team

2018-12-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Principle diagnosis of adhesive small bowel obstruction

You may not qualify if…

• Evidence of strangulation on initial CT scan leading to emergent operation
• Any known allergy to either contrast agent

Where it is running

• The Guthrie Clinic — Sayre, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.